| P2093 | author name string | Patierno SR | |
| | Manning FC | |
| P2860 | cites work | Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 |
| | Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 |
| | p53 mutations in human cancers | Q28302973 |
| | Bax-deficient mice with lymphoid hyperplasia and male germ cell death | Q28589360 |
| | Cycloheximide can rescue heat-shocked L cells from death by blocking stress-induced apoptosis | Q41611787 |
| | Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. | Q41612888 |
| | Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells | Q41637205 |
| | Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia | Q41714603 |
| | Clastogenicity of lead chromate particles in hamster and human cells | Q42062441 |
| | Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells | Q42070324 |
| | Effects of cycloheximide on B-chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis | Q42372311 |
| | A natural killer cell granule protein that induces DNA fragmentation and apoptosis | Q42768665 |
| | Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. | Q43212148 |
| | A novel form of Epstein-Barr virus latency in normal B cells in vivo | Q45789413 |
| | Apoptosis is the mode of cell death caused by carcinogenic chromium | Q50772912 |
| | Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. | Q52486527 |
| | The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cells. | Q52515744 |
| | Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. | Q53469533 |
| | Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. | Q53481792 |
| | A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel | Q53485594 |
| | Chromium (VI)-induced DNA damage in chick embryo liver and blood cells in vivo. | Q53533240 |
| | Analysis of residual amino acid--DNA crosslinks induced in intact cells by nickel and chromium compounds. | Q54260837 |
| | Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression | Q57937792 |
| | Induction of apoptosis in fibroblasts by c-myc protein | Q29614346 |
| | p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 |
| | Cell death: the significance of apoptosis | Q29617620 |
| | Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 |
| | Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 | Q29622924 |
| | Apoptotic cell death induced by c-myc is inhibited by bcl-2. | Q34255589 |
| | Social controls on cell survival and cell death | Q34372181 |
| | Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway | Q34889125 |
| | Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells | Q35088549 |
| | Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. | Q35208579 |
| | A biochemical hallmark of apoptosis: internucleosomal degradation of the genome | Q35233718 |
| | Apoptosis induced by anticancer drugs | Q35233723 |
| | Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview | Q35370212 |
| | Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis | Q35975984 |
| | The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants | Q35992367 |
| | Toward an understanding of the molecular mechanisms of physiological cell death. | Q36073702 |
| | Apoptosis induced by inhibition of intercellular contact | Q36234206 |
| | Apoptosis. Biochemical events and relevance to cancer chemotherapy | Q36360000 |
| | Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells | Q36362500 |
| | Programmed cell death: apoptosis and oncogenesis. | Q36399233 |
| | Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 | Q36678903 |
| | Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts | Q36721678 |
| | Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1 | Q36920336 |
| | Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. | Q37013182 |
| | Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? | Q37030033 |
| | Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1 | Q37058555 |
| | Induction of endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly(ADP-ribose) polymerase | Q37160809 |
| | The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins | Q37162513 |
| | The p53 tumour suppressor gene | Q37751892 |
| | A thousand and one protein kinases | Q39596528 |
| | Molecular and cellular basis of chemically induced immunotoxicity | Q39767346 |
| | A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma | Q40116728 |
| | The bcl-2 gene family | Q40406139 |
| | Characterization of radiation-induced apoptosis in the small intestine and its biological implications | Q40620918 |
| | The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. | Q40722479 |
| | Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids | Q40800750 |
| | Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis | Q41087255 |
| | Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia | Q41467765 |
| | Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells | Q41483255 |
| | Rapid activation of apoptosis in human promyelocytic leukemic cells by (+/-)-anti-benzo[a]pyrene diol epoxide induced DNA damage | Q41508497 |
| | The protooncogene bcl-2 inhibits apoptosis in PC12 cells | Q41570302 |
| | Inhibition of apoptosis in human tumour cells by okadaic acid | Q41591540 |
| P433 | issue | 5 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 455-465 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Cancer Investigation | Q325953 |
| P1476 | title | Apoptosis: inhibitor or instigator of carcinogenesis? | |
| P478 | volume | 14 | |